Domingo R.
About Domingo R.
Domingo Rodriguez Executive Vice President
Domingo Rodriguez serves as the Executive Vice President of Global Clinical Operations. In his current role, he oversees clinical development and operations on a global scale, leveraging his extensive expertise in various medical and therapeutic areas. With a career spanning over three decades, Domingo has been tasked with optimizing clinical programs and ensuring regulatory compliance across multiple regions.
Education and Medical Training
Domingo Rodriguez completed his medical education at CETEC University in the Dominican Republic. This foundational education paved the way for a career marked by significant roles in clinical and operational leadership within the biotechnology, pharmaceutical, and medical device sectors. The skills and knowledge gained during his training have been instrumental in his professional development.
Professional Background in Biotechnology and Pharmaceuticals
Domingo Rodriguez has accumulated over 30 years of experience in the biotechnology, pharmaceutical, and device industries. He has previously served as Vice President of Global Development Operations at Mallinckrodt Pharmaceuticals. From 2004 to 2013, he worked at GTx, Inc. as the Vice President of Clinical Operations. These roles have equipped him with a deep understanding of clinical operations and global development strategies.
Expertise in Clinical Development and Medical Affairs
Domingo Rodriguez brings a wealth of expertise in Clinical Development and Medical Affairs. He is skilled in conducting due diligence, managing acquisitions, integrations, FDA inspections, and developing sales and marketing strategies. His technical proficiency spans across multiple therapeutic areas, including oncology, male health, autoimmune diseases, and rare diseases.
Specialized Areas and Therapeutic Experience
Domingo Rodriguez specializes in various fields of medicine, particularly in neurology, rheumatology, nephrology, pulmonology, ophthalmology, regenerative medicine, immunotherapy, and neonatal respiratory critical care therapies. In addition, he has experience in handling transplants, analgesics, pediatrics, orphan/rare diseases, and medical devices. His broad-ranging expertise supports his leadership in advancing global clinical operations.